Cargando…
Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said!
Autores principales: | Honore, Patrick M., De Bels, David, Kugener, Luc, Redant, Sebastien, Attou, Rachid, Gallerani, Andrea, Spapen, Herbert D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795049/ https://www.ncbi.nlm.nih.gov/pubmed/31637184 http://dx.doi.org/10.2478/jtim-2019-0018 |
Ejemplares similares
-
Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
por: Honore, Patrick M., et al.
Publicado: (2019) -
Treatment of influenza virus-related critical illness during continuous renal replacement therapy: take caution with dosing
por: Honore, Patrick M., et al.
Publicado: (2020) -
No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020) -
Validity of the relationship between mobility group box-1 protein and poor post–cardiac arrest neurological outcome during renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019) -
Who may benefit most from future vitamin D intervention trials: do not forget patients on continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2020)